乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

ASCO Expert Roundtable: NSCLC

<乌鸦传媒 class="page-description">Expert Roundtable from the American Society of Clinical Oncology
ASCO 2032: What Will Be the Big Story in Lung Cancer?

Our roundtable of experts predict what the future holds for treatment of the disease

image
<乌鸦传媒 class="section_title">Latest ASCO Expert Roundtable: NSCLC Meeting Coverage
Unmet Needs in Lung Cancer

Our roundtable of experts discuss what other lung cancer areas they'd like to see more of at ASCO

June 29, 2022
Top Takeaways in Lung Cancer From ASCO 2022

Our roundtable of experts each offer two studies they believe to be most impactful

June 22, 2022
Neoadjuvant Chemo Plus Immunotherapy in Resectable NSCLC

Our roundtable of experts offer their consensus on the options now available for patients

June 15, 2022
Chemo-IO Over IO Alone in Patients With Advanced NSCLC

Our expert panel debates treatment options for the patient with a PDL1 score of 1-49%

July 13, 2021
Genomic Test in Lung Cancer: Waiting Is the Hardest Part

Our expert roundtable discusses how they the treat NSCLC patients who are waiting on NGS results

July 6, 2021
What the New KRAS Inhibitor Means for Lung Cancer

Our expert panel discusses the recently FDA-approved treatment for NSCLC patients

June 29, 2021
What Did We Learn From IMpower010 in Resectable NSCLC?

Our expert roundtable debates the value of the study analyses

June 22, 2021
<乌鸦传媒 class="section_title"> Latest Oncology/Hematology Meeting Coverage